Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Acta Psychiatr Scand
    April 2024
  1. DALAL TC, Liang L, Silva AM, Mackinley M, et al
    Speech based natural language profile before, during and after the onset of psychosis: A cluster analysis.
    Acta Psychiatr Scand. 2024 Apr 10. doi: 10.1111/acps.13685.
    >> Share

    February 2024
  2. BERGQVIST J, Hedskog S, Hedman C, Schultz T, et al
    Patients with both cancer and psychosis-to what extent do they receive specialized palliative care.
    Acta Psychiatr Scand. 2024 Feb 18. doi: 10.1111/acps.13666.
    >> Share

  3. TSUKAHARA M, So R, Yoshimura Y, Nakajima S, et al
    Response to the letter to the Editor from Araujo and colleagues on the research article entitled, "Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year r
    Acta Psychiatr Scand. 2024 Feb 15. doi: 10.1111/acps.13674.
    >> Share

    January 2024
  4. ARAUJO MB, Nogueira GN, Silveira PLSD, de Souza Junior SA, et al
    Insights and improvements: A critical analysis of methodological limitations in the investigation of smoking and valproic acid in treatment-resistant schizophrenia.
    Acta Psychiatr Scand. 2024 Jan 23. doi: 10.1111/acps.13659.
    >> Share

  5. DREVINSKAITE M, Kaceniene A, Patasius A, Stukas R, et al
    Cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
    Acta Psychiatr Scand. 2024 Jan 3. doi: 10.1111/acps.13651.
    >> Share

    December 2023
  6. EDVARDSEN E, Moszkowicz M, Olsen AL, Heinrichsen M, et al
    Clinical and sociodemographic features in offspring aged 0-3 years of mothers with schizophrenia spectrum disorders. A descriptive cross-sectional study.
    Acta Psychiatr Scand. 2023 Dec 10. doi: 10.1111/acps.13641.
    >> Share

  7. OLOYEDE E, Dima A, Taylor D, Cheung H, et al
    Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review.
    Acta Psychiatr Scand. 2023;148:538-552.
    >> Share

    November 2023
  8. JOHN AP, Mya T, Haywood D
    Cognitive deficits among people with schizophrenia and prediabetes or diabetes.
    Acta Psychiatr Scand. 2023 Nov 10. doi: 10.1111/acps.13627.
    >> Share

    September 2023
  9. TSUKAHARA M, So R, Yoshimura Y, Yamashita R, et al
    Effect of smoking habits and concomitant valproic acid use on relapse in patients with treatment-resistant schizophrenia receiving clozapine: A 1-year retrospective cohort study.
    Acta Psychiatr Scand. 2023 Sep 8. doi: 10.1111/acps.13612.
    >> Share

    August 2023
  10. CHENG CS, Chen WY, Chang HM, Pan CH, et al
    Unfavorable cancer mortality-to-incidence ratios in patients with schizophrenia: A nationwide cohort study in Taiwan, 2000-2019.
    Acta Psychiatr Scand. 2023 Aug 21. doi: 10.1111/acps.13604.
    >> Share

  11. VOCHOSKOVA K, McWhinney SR, Fialova M, Kolenic M, et al
    Weight and metabolic changes in early psychosis-association with daily quantification of medication exposure during the first hospitalization.
    Acta Psychiatr Scand. 2023 Aug 1. doi: 10.1111/acps.13594.
    >> Share

    May 2023
  12. KOHLER-FORSBERG O, Antonsen S, Pedersen CB, Mortensen PB, et al
    Schizophrenia spectrum disorders in Denmark between 2000 and 2018: Incidence and early diagnostic transition.
    Acta Psychiatr Scand. 2023 May 26. doi: 10.1111/acps.13565.
    >> Share

    April 2023
  13. ALLEBECK P, Gunnarsson T, Lundin A, Lofving S, et al
    Does a history of cannabis use influence onset and course of schizophrenia?
    Acta Psychiatr Scand. 2023 Apr 24. doi: 10.1111/acps.13562.
    >> Share

    March 2023
  14. VALLI I, Segura AG, Verdolini N, Garcia-Rizo C, et al
    Obstetric complications and genetic risk for schizophrenia: differential role of antenatal and perinatal events in first episode psychosis.
    Acta Psychiatr Scand. 2023 Mar 13. doi: 10.1111/acps.13546.
    >> Share

  15. WILLIAMS TF, Walker EF, Strauss GP, Woods SW, et al
    The reliability and validity of the Revised Green et al. Paranoid Thoughts Scale in individuals at clinical high-risk for psychosis.
    Acta Psychiatr Scand. 2023 Mar 11. doi: 10.1111/acps.13545.
    >> Share

    December 2022
  16. LI Z, Wang Y, Wang Z, Kong L, et al
    Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Acta Psychiatr Scand. 2022 Dec 30. doi: 10.1111/acps.13530.
    >> Share

    September 2022
  17. SANCHEZ-GUTIERREZ T, Barbeito S, Gomez-Juncal R, Rodriguez-Ortega E, et al
    Neuropsychological Functioning and Suicidal Behaviours in Patients with First-Episode Psychosis: A Systematic Review.
    Acta Psychiatr Scand. 2022 Sep 25. doi: 10.1111/acps.13501.
    >> Share

  18. PURANEN A, Koponen M, Lahteenvuo M, Tanskanen A, et al
    Real-world effectiveness of mood stabilizer use in schizophrenia.
    Acta Psychiatr Scand. 2022 Sep 5. doi: 10.1111/acps.13498.
    >> Share

  19. STOGIOS N, Maksyutynska K, Navagnanavel J, Sanches M, et al
    Metformin for the prevention of clozapine-induced weight gain: A retrospective naturalistic cohort study.
    Acta Psychiatr Scand. 2022;146:190-200.
    >> Share

    July 2022
  20. GYLLENBERG D, Ristikari T, Kelleher I, Kaariala A, et al
    School Performance and Later Diagnoses of Non-Affective Psychoses, Bipolar Disorder and Depression.
    Acta Psychiatr Scand. 2022 Jul 25. doi: 10.1111/acps.13481.
    >> Share

  21. BENROS ME
    High-quality large-scale longitudinal studies with detailed multimodal immunological phenotyping are warranted to disentangle the involvement of the immune system in psychosis.
    Acta Psychiatr Scand. 2022;146:3-5.
    >> Share

    May 2022
  22. FACAL F, Arrojo M, Paz E, Paramo M, et al
    Association between psychiatric hospitalizations of patients with schizophrenia and polygenic risk scores based on genes with altered expression by antipsychotics.
    Acta Psychiatr Scand. 2022 May 18. doi: 10.1111/acps.13444.
    >> Share

    April 2022
  23. BAANDRUP L, Allerup P, Nielsen MO, During SW, et al
    Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models.
    Acta Psychiatr Scand. 2022 Apr 13. doi: 10.1111/acps.13434.
    >> Share

    March 2022
  24. SPILKA MJ, Keller WR, Buchanan RW, Gold JM, et al
    Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia.
    Acta Psychiatr Scand. 2022 Mar 4. doi: 10.1111/acps.13421.
    >> Share

    February 2022
  25. DUNLEAVY C, Elsworthy RJ, Upthegrove R, Wood SJ, et al
    Inflammation in First-Episode Psychosis: The Contribution of Inflammatory Biomarkers to the Emergence of Negative Symptoms, A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2022 Feb 24. doi: 10.1111/acps.13416.
    >> Share

  26. MORENO-KUSTNER B, Fabrega-Ruz J, Gonzalez-Caballero JL, Reyes S, et al
    The Patient-Reported Impact of Symptoms in Schizophrenia Scale (PRISS): Development and Validation.
    Acta Psychiatr Scand. 2022 Feb 21. doi: 10.1111/acps.13417.
    >> Share

  27. VERDOLINI N, Borras R, Sparacino G, Garriga M, et al
    The prodromal phase: Differences in prodromal symptoms, risk factors and markers of vulnerability in first episode mania versus first episode psychosis with onset in late adolescence or adulthood.
    Acta Psychiatr Scand. 2022 Feb 16. doi: 10.1111/acps.13415.
    >> Share

  28. BRODEUR S, Vanasse A, Courteau J, Stip E, et al
    Comparative Effectiveness and Safety of Antipsychotic Drugs in Patients with Schizophrenia Initiating or Reinitiating Treatment: A Real-World Observational Study.
    Acta Psychiatr Scand. 2022 Feb 14. doi: 10.1111/acps.13413.
    >> Share

  29. TESLI M, Degerud E, Plana-Ripoll O, Gustavson K, et al
    Educational attainment and mortality in schizophrenia.
    Acta Psychiatr Scand. 2022 Feb 13. doi: 10.1111/acps.13407.
    >> Share

  30. BRODEUR S, Vanasse A, Courteau J, Courteau M, et al
    Antipsychotic Utilization Trajectories Three Years After Initiating or Reinitiating Treatment of Schizophrenia: A State Sequence Analysis Approach.
    Acta Psychiatr Scand. 2022 Feb 12. doi: 10.1111/acps.13411.
    >> Share

    January 2022
  31. MURILLO-GARCIA N, Diaz-Pons A, Fernandez-Cacho LM, Miguel-Cossrredera M, et al
    A family study on first episode of psychosis patients: exploring neuropsychological performance as an endophenotype.
    Acta Psychiatr Scand. 2022 Jan 25. doi: 10.1111/acps.13404.
    >> Share

  32. BALLESTER PL, Romano MT, de Azevedo Cardoso T, Hassel S, et al
    Brain age in mood and psychotic disorders: a systematic review and meta-analysis.
    Acta Psychiatr Scand. 2022;145:42-55.
    >> Share

    December 2021
  33. LOPEZ-DIAZ A, Ayesa-Arriola R, Ortiz-Garcia de la Foz V, Suarez-Pinilla P, et al
    Predictors of diagnostic stability in brief psychotic disorders: Findings from a 3-year longitudinal study.
    Acta Psychiatr Scand. 2021;144:578-588.
    >> Share

    November 2021
  34. NIELSEN J
    Clozapine treatment in a wider context: From before eligibility to life beyond clozapine.
    Acta Psychiatr Scand. 2021;144:419-421.
    >> Share

  35. SISKIND D, Sharma M, Pawar M, Pearson E, et al
    Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis.
    Acta Psychiatr Scand. 2021;144:422-432.
    >> Share

    October 2021
  36. MUSTAFA SS, Malla A, Joober R, Abadi S, et al
    Unfinished business: Functional outcomes in a randomized controlled trial of a three-year extension of early intervention versus regular care following two years of early intervention for psychosis.
    Acta Psychiatr Scand. 2021 Oct 2. doi: 10.1111/acps.13377.
    >> Share

    September 2021
  37. PARK CI, Han M, Jung I, Kim EH, et al
    A nationwide nested case-control study of new-onset obsessive-compulsive disorder following antipsychotics use in schizophrenia.
    Acta Psychiatr Scand. 2021 Sep 26. doi: 10.1111/acps.13375.
    >> Share

    August 2021
  38. SMITH E, Singh R, Lee J, Colucci L, et al
    Adiposity in Schizophrenia: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Aug 30. doi: 10.1111/acps.13365.
    >> Share

  39. KRISTENSEN TD, Glenthoj LB, Ambrosen K, Syeda W, et al
    Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra-high risk for psychosis.
    Acta Psychiatr Scand. 2021 Aug 1. doi: 10.1111/acps.13355.
    >> Share

  40. HSU CW, Tseng PT, Tu YK, Lin PY, et al
    Month of birth and mental disorders: A population-based study and validation using global meta-analysis.
    Acta Psychiatr Scand. 2021;144:153-167.
    >> Share

    July 2021
  41. FUJIWARA M, Yamada Y, Shimazu T, Kodama M, et al
    Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial.
    Acta Psychiatr Scand. 2021 Jul 9. doi: 10.1111/acps.13348.
    >> Share

  42. SUAREZ-PINILLA P, Suarez-Pinilla M, Setien-Suero E, Ortiz-Garcia de la Foz V, et al
    Stability of schizophrenia diagnosis in a ten-year longitudinal study on first episode of non-affective psychosis: conclusions from the PAFIP cohort.
    Acta Psychiatr Scand. 2021 Jul 6. doi: 10.1111/acps.13344.
    >> Share

  43. BARCELLA CA, Polcwiartek C, Mohr GH, Hodges G, et al
    Severe mental illness is associated with increased mortality and severe course of COVID-19.
    Acta Psychiatr Scand. 2021;144:82-91.
    >> Share

    June 2021
  44. BHAVSAR V, Kepinska AP
    Schizophrenia, catatonic schizophrenia and poliovirus - a role for natural experiments?
    Acta Psychiatr Scand. 2021;143:469-471.
    >> Share

    May 2021
  45. SHOHAM N, Eskinazi M, Hayes JF, Lewis G, et al
    Associations Between Psychosis and Visual Acuity Impairment: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 May 24. doi: 10.1111/acps.13330.
    >> Share

    April 2021
  46. MARWAHA S, Hett D, Johnson S, Fowler D, et al
    The impact of manic symptoms in first-episode psychosis: findings from the UK National EDEN study.
    Acta Psychiatr Scand. 2021 Apr 16. doi: 10.1111/acps.13307.
    >> Share

  47. SANKARANARAYANAN A, Pratt R, Anoop A, Smith A, et al
    Serum Lipids and Suicidal Risk among Patients with Schizophrenia Spectrum Disorders: Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 Apr 9. doi: 10.1111/acps.13305.
    >> Share

  48. WHISKEY E, Barnard A, Oloyede E, Dzahini O, et al
    An evaluation of the variation and underuse of clozapine in the United Kingdom.
    Acta Psychiatr Scand. 2021;143:339-347.
    >> Share

    March 2021
  49. VAN DER ZALM Y, Foldager L, Termorshuizen F, Sommer IE, et al
    Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study.
    Acta Psychiatr Scand. 2021;143:216-226.
    >> Share

  50. YADA Y, Kitagawa K, Sakamoto S, Ozawa A, et al
    The relationship between plasma clozapine concentration and clinical outcome: a cross-sectional study.
    Acta Psychiatr Scand. 2021;143:227-237.
    >> Share

    March 2020
  51. KAROW A, Brettschneider C, Helmut Konig H, Correll CU, et al
    Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis.
    Acta Psychiatr Scand. 2020;141:221-230.
    >> Share

  52. RUBIO JM, Kane JM
    How and when to use clozapine.
    Acta Psychiatr Scand. 2020;141:178-189.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016